Christine M. Barbon
Bluefin Biomedicine (United States)(US)AstraZeneca (United States)(US)
Publications by Year
Research Areas
Adenosine and Purinergic Signaling, T-cell and B-cell Immunology, RNA Interference and Gene Delivery, Lysosomal Storage Disorders Research, Immune Cell Function and Interaction
Most-Cited Works
- → AAV2 Vector Harboring a Liver-Restricted Promoter Facilitates Sustained Expression of Therapeutic Levels of α-Galactosidase A and the Induction of Immune Tolerance in Fabry Mice(2003)135 cited
- → Small molecule AZD4635 inhibitor of A2AR signaling rescues immune cell function including CD103+ dendritic cells enhancing anti-tumor immunity(2020)97 cited
- → Correction of the Biochemical and Functional Deficits in Fabry Mice Following AAV8–mediated Hepatic Expression of α-galactosidase A(2006)88 cited
- → The effects of storage temperature on PBMC gene expression(2016)80 cited
- → AAV8-Mediated Hepatic Expression of Acid Sphingomyelinase Corrects the Metabolic Defect in the Visceral Organs of a Mouse Model of Niemann–Pick Disease(2005)49 cited
- → Bactericidal/Permeability-Increasing Protein (rBPI 21 ) and Fluoroquinolone Mitigate Radiation-Induced Bone Marrow Aplasia and Death(2011)43 cited
- → Consecutive low doses of cyclophosphamide preferentially target Tregs and potentiate T cell responses induced by DNA PLG microparticle immunization(2010)37 cited
- → Alloanergization of Human T Cells Results in Expansion of Alloantigen-Specific CD8+CD28− Suppressor Cells(2014)26 cited
- → Ex Vivo Alloanergization with Belatacept: A Strategy to Selectively Modulate Alloresponses after Transplantation(2012)20 cited
- → In vivo electroporation enhances the potency of poly-lactide co-glycolide (PLG) plasmid DNA immunization(2010)16 cited